Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Clinical trials show semaglutide monotherapy produces 10-15% body weight reduction on average, with some patients exceeding 20% loss
It should not be used in people with a personal or family history of medullary thyroid carcinoma or in those with multiple endocrine neoplasia syndrome type 2, unless a doctor decides otherwise based on local guidance
Cancer syndromes
Unlike short-acting peptides requiring precise timing, Tirzepatide provides steady metabolic support throughout the week
US$ 21.71
US$ 25.38
US$ 26.79
US$ 25.00
US$ 24.02
US$ 23.20
US$ 22.79
US$ 28.66
US$ 23.70
US$ 20.89
US$ 23.72
US$ 23.77
